BIOGY Stock - BioGaia AB (publ)
Unlock GoAI Insights for BIOGY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.30B | $1.10B | $785.11M | $747.08M |
| Gross Profit | $1.03B | $950.19M | $801.93M | $582.95M | $546.92M |
| Gross Margin | 72.4% | 73.3% | 72.6% | 74.3% | 73.2% |
| Operating Income | $423.37M | $443.10M | $361.46M | $253.74M | $228.15M |
| Net Income | $351.39M | $365.35M | $373.77M | $196.27M | $179.73M |
| Net Margin | 24.7% | 28.2% | 33.9% | 25.0% | 24.1% |
| EPS | $3.48 | $3.62 | $3.70 | $1.94 | $1.78 |
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Visit WebsiteEarnings History & Surprises
BIOGYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 10, 2026 | — | — | — | — |
Q4 2025 | Oct 20, 2025 | — | $0.01 | — | — |
Q3 2025 | Jul 18, 2025 | — | $0.09 | — | — |
Q2 2025 | May 7, 2025 | — | $0.79 | — | — |
Q1 2025 | Feb 12, 2025 | — | $0.81 | — | — |
Q4 2024 | Oct 22, 2024 | — | $0.36 | — | — |
Q3 2024 | Jul 23, 2024 | — | $1.10 | — | — |
Q2 2024 | May 7, 2024 | — | $1.21 | — | — |
Q1 2024 | Feb 7, 2024 | — | $1.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.67 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.80 | — | — |
Q1 2023 | Mar 31, 2023 | — | $1.15 | — | — |
Q4 2022 | Dec 31, 2022 | — | $1.38 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.79 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.78 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.76 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.38 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.52 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.54 | — | — |
Latest News
Frequently Asked Questions about BIOGY
What is BIOGY's current stock price?
What is the analyst price target for BIOGY?
What sector is BioGaia AB (publ) in?
What is BIOGY's market cap?
Does BIOGY pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BIOGY for comparison